The Post-Click Gap: How the Best AI Tool for Phishing Triage Track Follow-on Activity 
Who Owns the Blast Radius When AI Acts Alone? 
ComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management System 
Stagwell Launches New Global Media Agency, Stagwell Media 
TMX Group Consolidated Trading Statistics – September 2026 Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category PRINCETON, N.J.,…
89bio to Present New Sub-Analysis from Phase 1b/2a NASH Study of BIO89-100 at AASLD’s The Liver Meeting 2021
Data from a new sub-analysis of the Phase 1b/2a study in NASH shows correlation between…
4D Molecular Therapeutics Reports Interim Results from the 4D-310 Phase 1/2 Clinical Trial in Patients with Fabry Disease and Provides Clinical Data Update from the 4D-110 Phase 1/2 Clinical Trial in Patients with Choroideremia
– First-ever clinical activity data reported on 4D-310 Fabry disease product candidate utilizing the proprietary…
ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) — ADMA Biologics, Inc….
Revelation Biosciences Inc. Engages Destum Partners Inc. to Identify Strategic Partners for REVTx-99 (Ex-US) and REVTx-200 (Worldwide)
-Anti-viral nasal drop REVTx-99 has potential to broadly prevent or treat respiratory infections including influenza,…
Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
CAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical…
Erasca Announces Presentation of Preclinical Data on ERAS-801, a CNS-Penetrant EGFR Inhibitor with Broad Activity against Oncogenic EGFR Alterations, at AACR Conference on Brain Cancer
ERAS-801’s CNS penetration: four times higher than approved EGFR inhibitorsComprehensive inhibition against oncogenic EGFR vIII…
Iovance Biotherapeutics to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 4, 2021
SAN CARLOS, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Gritstone Announces Presentations during Five Upcoming Investor Conferences and Events
EMERYVILLE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Todos Medical Announces Publication in Nature Neuroscience That Describes the Main Protease (3CL Protease) Causes Microvascular Brain Pathology
New York, NY, and Tel Aviv, ISRAEL, Oct. 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
INmune Bio, Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, November 3
Management to host conference call and webcast at 4:30 pm ET on that day Boca…
Panbela Schedules Conference Call on November 10, 2021, to Report 2021 Third Quarter Financial Results
MINNEAPOLIS , Oct. 25, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergic Reactions
First and only orally delivered epinephrine product candidate AQST-109 demonstrates clinical results comparable to autoinjectors…
Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
Conference Call on Tuesday, November 9, 2021, at 8:30 a.m. ET LEXINGTON, Mass., Oct. 25,…
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
EWING, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”),…
Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program
Nomacopan eyedrops reduced inflammation more than both standard treatments cyclosporin and the steroid dexamethasone in…
Genetic Technologies Reports Q1 FY22 Results
Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts…
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
The Company will host a Conference Call and Webcast on November 10, 2021, at 8:30…
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2021 Financial Results
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…